Dihydropyrimidine Dehydrogenase (DPD)

Dihydropyrimidine Dehydrogenase (DPD) is a pyrimidine catabolic enzyme that catalyzes the two-electron reduction of pyrimidine bases uracil and thymine. Dihydropyrimidine dehydrogenase catalyzes the first step of pyrimidine catabolism by promoting the reduction of the 5,6-vinylic bond of thymine or uracil with electrons acquired from NADPH. Mammalian Dihydropyrimidine dehydrogenase is a functional homodimer and each subunit contains an FAD, an FMN and four Fe4S4 centers with two Fe4S4 centers from each subunit forming an electron transfer conduit that link the flavins within each subunit. Dihydropyrimidine dehydrogenase accepts the pervasive chemotherapeutic 5-Fluorouracil as a substrate, severely shortening its pharmacological half-life and dictating the use of elaborate compensatory administration protocols to achieve efficacious toxicity[1].

By Effects: Inhibitor (3)
共 3种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
5-Iodouracil

5-Iodouracil(Compound 4b)是一种不可逆的二氢嘧啶脱氢酶(DPD)抑制剂(IC50=0.22 μM),有望用于非小细胞肺癌(NSCLC)等DPD过表达实体瘤的研究。

696-07-1
Inhibitor
99.95%
5-Iodouracil
DFP-11207

DFP-11207 是一种具有口服活性的氟嘧啶类细胞毒性试剂,它将 5-FU 前药与可逆的 DPD 抑制剂及强效的 OPRT 抑制剂相结合,从而增强 5-FU 的药理活性,同时降低胃肠道毒性和骨髓抑制毒性,可用于癌症研究。

1296177-16-6
Inhibitor
DFP-11207
Ro-09-4889

Ro-09-4889 是一种前药,可通过剂量依赖性的方式抑制二氢嘧啶脱氢酶 (DPD) 活性,并可用于癌症研究。

216449-60-4
Inhibitor
Ro-09-4889

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础